MedTrace Logo

Acupuncture for Pain of Endometriosis

NCT03125304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2021-10-19

No results posted yet for this study

Summary

This proposed trial is a multicenter,randomized and controlled clinical trial. The aim of this trial is to evaluate the efficacy and safety of acupuncture for treating pain of Endometriosis.The trial period will consist of three menstrual cycles of treatment, and three menstrual cycles in the follow-up period.We put forward the following hypothesis: the effect of acupuncture group is better than the control group on relieving pain.

Conditions

  • Endometriosis

Interventions

OTHER

acupuncture

They will be treated seven days before expected menstrual onset with once a day and three times a week for therapy. During the menstrual period,they will be treated everyday when they are having pain.Every treatment lasts 30 minutes. The trial period will consist of three menstrual cycles of treatment and three menstrual cycles in the follow-up period.

Sponsors & Collaborators

  • The Affiliated Hospital of JiangXi University of TCM

    collaborator UNKNOWN

  • The Qionghai Hospital of TCM

    collaborator UNKNOWN

  • The GanZhou Maternal and Child Health Hospital

    collaborator UNKNOWN

  • The Second Affiliated Hospital of JiangXi University TCM

    collaborator UNKNOWN

  • State Administration of Traditional Chinese Medicine of the People's Republic of China

    lead OTHER_GOV

Principal Investigators

  • Ruining Liang · The Second Affiliated Hospital of Jiangxi University of TCM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-21
Primary Completion
2021-03-26
Completion
2021-06-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03125304 on ClinicalTrials.gov